Cervical cryotherapy for condylomata acuminata during pregnancy

Area of Science:

• Obstetrics and Gynecology
• Dermatology
• Viral Infections

Background:

• Cervical condylomata acuminata (genital warts) can pose treatment challenges during pregnancy.
• The safety and efficacy of treatments during pregnancy require careful consideration.

Purpose of the Study:

• To evaluate the safety and effectiveness of cryotherapy for treating cervical condylomata acuminata in pregnant patients.
• To assess any potential adverse effects on pregnancy outcomes and neonates.

Main Methods:

• Twenty-eight pregnant patients in their second and third trimesters received cryotherapy for cervical condylomata acuminata.
• Treatment outcomes, including resolution rates, postpartum status, and pregnancy complications, were monitored.

Main Results:

• Most patients required two cryotherapy sessions for complete resolution of condylomata acuminata.
• All patients responded favorably with no residual disease at six weeks postpartum.
• No adverse effects on pregnancy, including no premature rupture of membranes, no induced labor, no cervical scarring, and normal deliveries were observed.
• No neonates were affected by the treatment.

Conclusions:

• Cryotherapy is an effective treatment for cervical condylomata acuminata during the second and third trimesters of pregnancy.
• The procedure is safe, with no identifiable adverse effects on pregnancy, delivery, or neonates.
• Cryotherapy offers a viable therapeutic option for managing cervical condylomata acuminata in late pregnancy.